The role of fluoxetine in the treatment of premenstrual dysphoric disorder
- 1 April 1999
- journal article
- review article
- Published by Elsevier in Clinical Therapeutics
- Vol. 21 (4) , 615-633
- https://doi.org/10.1016/s0149-2918(00)88315-0
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Comparison of Fluoxetine, Bupropion, and Placebo in the Treatment of Premenstrual Dysphoric DisorderJournal of Clinical Psychopharmacology, 1997
- Estrogen increases the density of 5-Hydroxytryptamine2A receptors in cerebral cortex and nucleus accumbens in the female ratThe Journal of Steroid Biochemistry and Molecular Biology, 1995
- The Serotonin Reuptake Inhibitor Paroxetin Is Superior to the Noradrenaline Reuptake Inhibitor Maprotiline in the Treatment of Premenstrual SyndromeNeuropsychopharmacology, 1995
- A central 5-HT2 receptor mechanism plays a key role in the proestrous surge of luteinizing hormone in the ratPsychoneuroendocrinology, 1994
- Anxiety and the menstrual cycle in panic disorderJournal of Affective Disorders, 1990
- Menstrual fluctuation in the symptoms of panic anxietyJournal of Affective Disorders, 1988
- Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndromeBiological Psychiatry, 1988
- Premenstrual exacerbation of binge eating in bulimiaAmerican Journal of Psychiatry, 1987
- The Epidemiology and Social Impact of Premenstrual SymptomsClinical Obstetrics and Gynecology, 1987
- Premenstrual Mood Changes: A Guide to Evaluation and TreatmentPsychiatric Annals, 1984